nach oben

Current Diabetes Reports

Erschienen in:

01.08.2011

Central Nervous System Involvement in Diabetic Neuropathy

verfasst von: Dinesh Selvarajah, Iain D. Wilkinson, Jennifer Davies, Rajiv Gandhi, Solomon Tesfaye

Erschienen in: Current Diabetes Reports | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Diabetic neuropathy is a chronic and often disabling condition that affects a significant number of individuals with diabetes. Long considered a disease of the peripheral nervous system, there is now increasing evidence of central nervous system involvement. Recent advances in neuroimaging methods detailed in this review have led to a better understanding and refinement of how diabetic neuropathy affects the central nervous system. Recognition that diabetic neuropathy is, in part, a disease that affects the whole nervous system is resulting in a critical rethinking of this disorder, opening a new direction for further research.

Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester diabetic neuropathy study. Neurology. 1993;43:817–24.PubMed

Forsblom CM, Sane T, Groop PH, Totterman KJ, Kallio M, Saloranta C, et al. Risk factors for mortality in type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia. 1998;4:1253–62.CrossRef

Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz R, Kempler P, et al. On behalf of the Toronto diabetic neuropathy expert group. diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity and treatments. Diabetes Care. 2010;33(10):2285–93.PubMedCrossRef

Daousi C, MacFarlane IA, Woodward A, et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med. 2004;21:976–82.PubMedCrossRef

Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29:1518–22.PubMedCrossRef

Tesfaye S. Advances in the management of painful diabetic neuropathy. Curr Opin Support Palliat Care. 2009;3(2):136–43.PubMedCrossRef

Gore M, Brandenburg N, Dukes, et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptoms manage. 2005;30:374–85.CrossRef

Zelman DC, Brandenburg NA, Gore M. Sleep impairment in patients with painful diabetic peripheral neuropathy. Clin J Pain. 2006;22(8):681–5.PubMedCrossRef

Benbow SJ, Wallymahmed ME, MacFarlane IA. Diabetic peripheral neuropathy and quality of life. Q J Med. 1998;91:733–7.

10.

Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diab Res Clin Pract. 2000;47(2):123–8.CrossRef

11.

Gore M, Brandenburg N, Hoffman DL, et al. Burden of illness in painful diabetic peripheral neuropathy: the patients’ perspectives. J Pain. 2006;7(12):892–900.PubMedCrossRef

12.

Tolle T, Xu X, Sadosky AB. Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns. J Diabet Complications. 2006;20:26–33.CrossRef

13.

Quattrini C, Tesfaye S. Understanding the impact of painful diabetic neuropathy. Diab Metab Res Rev. 2003;19:S2–8.CrossRef

14.

Watkins PJ. Pain and diabetic neuropathy. Br Med J. 1984;288:168–9.CrossRef

15.

National Institute of Diabetes and Digestive and Kidney Diseases: National Diabetes Statistics. Accessed May 10, 2011. Available at 2011http://diabetes.niddk.nih.gov/dm/pubs/statistics/#allages

16.

Jensen T, Baconja MM, Jimenez H, Tesfaye S, Valensi P, Ziegler. Management of diabetic neuropathic pain. Diab Vas Dis Res. 2006;3:108–19.CrossRef

17.

Diabetic Neuropathy. Tesfaye S, Boulton AJ (eds), Oxford University Press, Oxford 2009

18.

Obrosova IG. Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics. 2009;6(4):638–47.PubMedCrossRef

19.

Said G, Slama G, Selva J. Progressive centripital degeneration of of axons in small fibre type diabetic polyneuropathy. A clinical and pathological study. Brain. 1983;106:791.PubMedCrossRef

20.

Malik RA, Newrick PG, Sharma AK, Jennings A, Ah-See AK, Mayhew TM, et al. Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia. 1989;32:92–102.PubMedCrossRef

21.

Tesfaye S, Malik R, Ward JD. Vascular factors in diabetic neuropathy. Diabetologia. 1994;37:847–54.PubMedCrossRef

22.

Malik RA, Tesfaye S, Thompson SD, Veves A, Boulton AJM, Ward JD. Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia. 1993;36:454–9.PubMedCrossRef

23.

Malik RA, Tesfaye S, Thompson SD, Veves A, Ward JD, Boulton AJM. Transperineurial capillary abnormalities in the sural nerve of patients with diabetic neuropathy. Microvas Res. 1994;48:236–45.CrossRef

24.

Giannini C, Dyck PJ. Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus. Ann Neurol. 1994;36:408–15.PubMedCrossRef

25.

Tesfaye S, Harris N, Jakubowski J, et al. Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia 36: 1266-1274.

26.

Tesfaye S, Malik R, Harris N, Jakubowski J, Mody C, Rennie IG, et al. Arteriovenous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia. 1996;39:329–35.PubMedCrossRef

27.

Ibrahim S, Harris ND, Radatz M, Selmi F, Rajbhandari S, Brady L, et al. A new minimally invasive technique to show nerve ischaemia in diabetic neuropathy. Diabetologia. 1999;42(6):737–42.PubMedCrossRef

28.

Newrick PG, Wilson AJ, Jakubowski J, Boulton AJM, Ward JD. Sural nerve oxygen tension in diabetes. Br Med J. 1986;193:1053–4.CrossRef

29.

Thomas PK. Mechanisms of neuropathic pain. In: Gries FA, Cameron NE, Low PA, Ziegler D, editors. Textbook of diabetic neuropathy. Stuttgart: Thieme; 2003. p. 208–11.

30.

Tesfaye S, Kempler P. Painful diabetic neuropathy. Diabetologia. 2005;48(5):805–7.PubMedCrossRef

31.

Young RJ. Structural functional interactions in the natural\history of diabetic polyneuropathy: a key to the understanding of neuropathic pain? Diabet Med. 1993;10 Suppl 2:87S–8S.

32.

Asbury AK, Fields HL. Pain due to peripheral nerve damage: an hypothesis. Neurology. 1984;34:1587–90.PubMed

33.

Wall PD, Gutnick M. Ongoing activity in peripheral nerves: the physiology and pharmacology of impulses originating in a neuroma. Exp Neurol. 1974;43:580–93.PubMedCrossRef

34.

Llewelyn JG, Gilbey SG, Thomas PK, et al. Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy: a clinico pathological study. Brain. 1991;114:867–92.PubMedCrossRef

35.

Britland ST, Young RJ, Sharma AK, et al. Acute remitting painful diabetic polyneuropathy: a comparison of peripheral nerve fibre pathology. Pain. 1992;48:361–70.PubMedCrossRef

36.

Oyibo S, Prasad YD, Jackson NJ, et al. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med. 2002;19:870–3.PubMedCrossRef

37.

Eaton SE, Harris ND, Ibrahim S, Patel K, Selmi F, Radatz M, Ward JD, Tesfaye S. Differnces insural nerve haemodynamics in painful and painless neuropathy. Diabetologia 2003; 934–939.

38.

Quattrini C, Harris ND, Malik RA, Tesfaye S. Impaired skin microvascular reactivity in painful diabetic neuropathy. Diabetes Care. 2007;30:655–9.PubMedCrossRef

39.

Sorensen L, Molyneaux L, Yue DK. The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care. 2006;29:883–7.PubMedCrossRef

40.

Gandhi R, Marques JLB, Selvarajah D, et al. Painful diabetic neuropathy is associated with greater autonomic dysfunction than painless diabetic neuropathy. Diabetes Care. 2010;33:1585–90.PubMedCrossRef

41.

Manschot SM, Brands AM, van der Grond J, Kessels RP, Algra A, Kappelle LJ. Utrecht diabetic encephalopathy study group. brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes. 2006;55(4):1106–13.PubMedCrossRef

42.

Mijnhout GS, Scheltens P, Diamant M, Biessels GJ, Wessels AM, Simsek S, et al. Diabetic encephalopathy: a concept in need of a definition. Diabetologia. 2006;49:1447–8.PubMedCrossRef

43.

Leichtentritt H. Erkrankung Peripherer nerven und des rucken-marks bei diabetes mellitus. Berlin: G. Schade; 1893. p. 32.

44.

Pryce, T. D. (1893). On diabetic neuritis with a clinical and pathological description of three cases of diabetic pseudo-tabes. Brain, 1.

45.

Williamson, R. T. (1904). Changes in the spinal cord in diabetes mellitus. Br Med J, 1.

46.

Reske-Nielsen E, Lundbaek K. Pathological changes in the central and peripheral nervous system of young long-term diabetics. II. The spinal cord and peripheral nerves. Diabetologia. 1968;4:34–43.PubMedCrossRef

47.

Reske-Nielsen E, Lundbaek K, et al. Pathological changes in the central and peripheral nervous system of young long-term diabetics. The terminal neuro-muscular apparatus. Diabetologia. 1970;6:98–103.PubMedCrossRef

48.

Tesfaye S, Watt J, et al. Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy. Lancet. 1996;348:1698–701.PubMedCrossRef

49.

Eaton SE, Harris ND, et al. Spinal-cord involvement in diabetic peripheral neuropathy. Lancet. 2001;358:35–6.PubMedCrossRef

50.

Selvarajah D, Wilkinson ID, Emery CJ, Harris ND, Shaw PJ, Witte DR, et al. Early involvement of the spinal cord in diabetic peripheral neuropathy. Diabetes Care. 2006;29:2664–9.PubMedCrossRef

51.

Pfeifer MA, Schumer MP. Clinical trials of diabetic neuropathy: past, present, and future. Diabetes. 1995;44:1355–61.PubMedCrossRef

52.

Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJ, O’Brien PC; Cl vs. NPhys Trial Investigators, Albers JW, Andersen H, Bolton CF, England JD, Klein CJ, Llewelyn JG, Mauermann ML, Russell JW, Singer W, Smith AG, Tesfaye S, Vella A. Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial. Muscle Nerve. 2010 Aug;42(2):157–164

53.

Dyck PJ, Norell JE, Tritschler H, Schuette K, Samigullin R, Ziegler D, et al. Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity. Diabetes Care. 2007;30:2619–25.PubMedCrossRef

54.

Wilkinson ID, Gandhi RA, Hunter MD, Emery CJ, Griffiths P, Selvarajah D, et al. Functional MRI and response to pain in diabetic neuropathy. Diabet Med. 2007;24 suppl 1:187.

55.

Wilson P, Kitchener PD, et al. Cutaneous receptive field organization in the ventral posterior nucleus of the thalamus in the common marmoset. J Neurophysiol. 1999;82:1865–75.PubMed

56.

McCormick DA, Bal T. Sensory gating mechanisms of the thalamus. Curr Opin Neurobiol. 1994;4:550–6.PubMedCrossRef

57.

Wilkinson ID, Griffiths PD, et al. Proton magnetic resonance spectroscopy of brain lesions in children with neurofibromatosis type 1. Magn Reson Imaging. 2001;19:1081–9.PubMedCrossRef

58.

Wilkinson ID, Hadjivassiliou M, et al. Cerebellar abnormalities on proton MR spectroscopy in gluten ataxia. J Neurol Neurosurg Psychiatry. 2005;76:1011–3.PubMedCrossRef

59.

Moffett JR, Namboodiri MA, et al. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport. 1991;2:131–4.PubMedCrossRef

60.

Simmons ML, Frondoza CG, et al. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience. 1991;45:37–45.PubMedCrossRef

61.

Urenjak J, Williams SR, et al. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci. 1993;13:981–9.PubMed

62.

Wilkinson ID, Lunn S, et al. Proton MRS and quantitative MRI assessment of the short term neurological response to antiretroviral therapy in AIDS. J Neurol Neurosurg Psychiatry. 1997;63:477–82.PubMedCrossRef

63.

Matthews PM, Andermann F, et al. A proton magnetic resonance spectroscopy study of focal epilepsy in humans. Neurology. 1990;40:985–9.PubMed

64.

De Stefano N, Matthews PM, et al. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med. 1995;34:721–7.PubMedCrossRef

65.

Tsai G, Coyle JT. N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol. 1995;46:531–40.PubMedCrossRef

66.

Hugg JW, Kuzniecky RI, et al. Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging. Ann Neurol. 1996;40:236–9.PubMedCrossRef

67.

Nakano M, Ueda H, et al. Measurement of regional N-acetylaspartate after transient global ischemia in gerbils with and without ischemic tolerance: an index of neuronal survival. Ann Neurol. 1998;44:334–40.PubMedCrossRef

68.

Sarac K, Akinci A, et al. Brain metabolite changes on proton magnetic resonance spectroscopy in children with poorly controlled type 1 diabetes mellitus. Neuroradiology. 2005;47:562–5.PubMedCrossRef

69.

Rankins D, Wellard RM, et al. The impact of acute hypoglycemia on neuropsychological and neurometabolite profiles in children with type 1 diabetes. Diabetes Care. 2005;28:2771–3.PubMedCrossRef

70.

Wootton-Gorges SL, Buonocore MH, et al. Detection of cerebral {beta}-hydroxy butyrate, acetoacetate, and lactate on proton MR spectroscopy in children with diabetic ketoacidosis. AJNR Am J Neuroradiol. 2005;26:1286–91.PubMed

71.

Kreis R, Ross BD. Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology. 1992;184:123–30.PubMed

72.

Geissler A, Frund R, et al. Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy. Exp Clin Endocrinol Diab. 2003;111:421–7.CrossRef

73.

Selvarajah D, Wilkinson ID, Emery CJ, Shaw PJ, Griffiths PD, Gandhi R, et al. Thalamic neuronal dysfunction and chronic sensorimotor distal symmetrical polyneuropathy in patients with type 1 diabetes mellitus. Diabetologia. 2008;51:2088–92.PubMedCrossRef

74.

Gandhi R, Selvarajah D, Emery CJ, Wilkinson ID, Tesfaye S. Neurochemical abnormalities within sensory pathways in the brain in diabetic neuropathy. Diabetologia. 2008;51(Supp 1):1–588.

75.

Sorensen L, Siddall PJ, Trenell MI, Yue DK. Differences in metabolites in pain-processing brain regions in patients with diabetes and painful neuropathy. Diabetes Care. 2008;31:980–1.PubMedCrossRef

76.

Østergaard L. Cerebral perfusion imaging by bolus tracking. Top Magn Reson Imaging. 2004;15:3–9.PubMedCrossRef

77.

Selvarajah D, Wilkinson ID, Gandhi R, Griffiths PD, Tesfaye S. Microvascular perfusion abnormalities of the thalamus in painful but Not painless diabetic polyneuropathy: a clue to the pathogenesis of pain in type 1 diabetes. Diabetes Care. 2011;34(3):718–20.PubMedCrossRef

78.

Lai MH, Wang TY, Chang CC, Li TY, Chang ST. Cerebellar diaschisis and contralateral thalamus hyperperfusion in a stroke patient with complex regional pain syndrome. J Clin Neurosci. 2008;15(10):1166–8.PubMedCrossRef

79.

Fischer TZ, Tan AM, Waxman SG. Thalamic neuron hyperexcitability and enlarged receptive fields in the STZ model of diabetic pain. Brain Res. 2009;1268:154–61.PubMedCrossRef

80.

Fischer TZ, Waxman SG. Neuropathic pain in diabetes–evidence for a central mechanism. Nat Rev Neurol. 2010;6(8):462–6.PubMedCrossRef

81.

Laterre EC, De Volder AG, Goffinet AM. Brain glucose metabolism in thalamic syndrome. J Neurol Neurosurg Psychiatry. 1988;51:427–8.PubMedCrossRef

82.

Di Piero V, Jones AK, Iannotti F, Powell M, Perani D, Lenzi GL, et al. Chronic pain: a PET study of the central effects of percutaneous high cervical cordotomy. Pain. 1991;46:9–12.PubMedCrossRef

83.

Hua SE, Garonzik IM, Lee JI, Lenz FA. Microelectrode studies of normal organization and plasticity of human somatosensory thalamus. J Clin Neurophysiol. 2000;17:559–74.PubMedCrossRef

84.

Moisset X, Bouhassira D. Brain imaging of neuropathic pain. Neuroimage 2077, Suppl 1, S80-S88.

85.

Iadarola MJ, Max MB, Berman KF, Byas-Smith MG, Coghill RC, Gracely RH, et al. Unilateral decrease in thalamic activity observed with positron emission tomography in patients with chronic neuropathic pain. Pain. 1995;63:55–64.PubMedCrossRef

86.

Hsieh JC, Belfrage M, Stone-Elander S, Hansson P, Ingvar M. Central representation of chronic ongoing neuropathic pain studied by positron emission tomography. Pain. 1995;63:225–36.PubMedCrossRef

87.

Woolf C, Mannion R. Neuropathic pain: aetiology, symptoms, mechanisms and management. Lancet. 1999;353:1959–64.PubMedCrossRef

88.

Tracey I. Imaging pain. Br J Anaesth. 2008;101:32–9.PubMedCrossRef

89.

Costigan, M., J. Scholtz, et al. (2009). "Neuropathic pain: A maladaptive response of the nervous system to damage." Annual Review of Neuroscience 32(1-32).

90.

Belfer I, Daif F. Phenotyping and genotyping neuropathic pain. Curr Pain Headache Rep. 2010;14:203–12.PubMedCrossRef

91.

Lassen N, Kanno I. Two methods for calculating regional cerebral blood flow from emission computed tomography of inert gas concentrations. J Comput Assist Tomogr. 1979;3:31–76.

92.

TalbotJD MS, Evans AC, et al. Multiple representations of pain in human cerebral cortex. Science. 1991;251:1355–8.CrossRef

93.

Apkarian A, Bushnell B, et al. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain. 2005;9:463–84.PubMedCrossRef

94.

Melzack R. From the gate to the neuromatrix. Pain. 1999;6(Suppl):S121–6.PubMedCrossRef

95.

Bushnell MC, Duncan GH, Hofbauer RK, Ha B, Chen JI, Carrier B. Pain perception: is there a role for primary somatosensory cortex? Proc Natl Acad Sci USA. 1999;96(14):7705–9.PubMedCrossRef

96.

Kanda M, Nagamine T, Ikeda A, Ohara S, Kunieda T, Fujiwara N, et al. Primary somatosensory cortex is actively involved in pain processing in human. Brain Res. 2000;853(2):282–9.PubMedCrossRef

97.

Peyron R, García-Larrea L, Grégoire MC, Convers P, Richard A, Lavenne F, et al. Parietal and cingulate processes in central pain. A combined positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) study of an unusual case. Pain. 2000;84(1):77–87.PubMedCrossRef

98.

Tracey I, Mantyh P. The Cerebral Signature for pain perception and its modulation. Neuron. 2007;55(3):377–91.PubMedCrossRef

99.

Wilkinson ID, Gandhi R, Hunter MD, Selvarajah D, Emery CJ, Griffiths PD, et al. A functional magnetic resonance imaging study demonstrating alterations in brain responses to acute pain stimulation in diabetic neuropathy. Diabetologia. 2007;50(Supp 1):1–538.

100.

Brooks J, Tracey I. From nociception to pain perception: imaging the spinal and supraspinal pathways. J Anat. 2005;207:19–33.PubMedCrossRef

101.

Valeriani M, Arendt-Nielsen L, Le Pera D, Restuccia D, Rosso T, De Armas L, et al. Short-term plastic changes of the human nociceptive system following acute pain induced by capsaicin. Clin Neurophysiol. 2003;114:1879–90.PubMedCrossRef

102.

Petrovic P, Ingvar M, Stone-Elander S, Petersson KM, Hansson P. A PET activation study of dynamic mechanical allodynia in patients with mononeuropathy. Pain. 1999;83:459–70.PubMedCrossRef

103.

Peyron R, García-Larrea L, Grégoire MC, Convers P, Lavenne F, Veyre L, et al. Allodynia after lateral-medullary (Wallenberg) infarct. PET study Brain. 1998;121:345–56.

104.

Zambreanu L et al. A role for the brainstem in central sensitisation in humans. Pain. 2005;114:397–407.PubMedCrossRef

105.

Witting N, Kupers RC, Svensson P, Arendt-Nielsen L, Gjedde A, Jensen TS. Experimental brush-evoked allodynia activates posterior parietal cortex. Neurology. 2001;57:1817–24.PubMed

106.

Becerra L, Morris S, Bazes S, Gostic R, Sherman S, Gostic J, et al. Trigeminal neuropathic pain alters responses in CNS circuits to mechanical (brush) and thermal (cold and heat) stimuli. J Neurosci. 2006;26:10646–57.PubMedCrossRef

107.

Schweinhardt P, Glynn C, Brooks J, McQuay H, Jack T, Chessell I, et al. An fMRI study of cerebral processing of brush-evoked allodynia in neuropathic pain patients. Neuroimage. 2006;32:256–65.PubMedCrossRef

108.

Tracey I, Mantyh PW. The cerebral signature for pain perception and its modulation. Neuron 55, 377–91.

Titel: Central Nervous System Involvement in Diabetic Neuropathy
verfasst von: Dinesh Selvarajah
Iain D. Wilkinson
Jennifer Davies
Rajiv Gandhi
Solomon Tesfaye
Publikationsdatum: 01.08.2011
Verlag: Current Science Inc.
Erschienen in: Current Diabetes Reports / Ausgabe 4/2011
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-011-0205-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Ablationstherapie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Central Nervous System Involvement in Diabetic Neuropathy

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2011

Oxidative Stress and Diabetic Kidney Disease

Is Duloxetine More Effective than Amitriptyline for Painful Diabetic Neuropathy?

Microvascular Modifications in Diabetic Retinopathy

Screening for the High-risk Foot of Ulceration: Tests of Somatic and Autonomic Nerve Function

What is the Role of Hyperbaric Oxygen in the Management of Diabetic Foot Disease?

The Goal of Blood Pressure Control for Prevention of Early Diabetic Microvascular Complications

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Innere Medizin